A new East Coast Fever vaccine diluent improvement project will be undertaken by GALVmed in partnership with the Malawi-based Centre for Ticks and Tick-borne Diseases (CTTBD) and the British-based biotechnology […]

GALVmed collaborated with PATH, a Seattle-based charity working on health care innovations in developing countries, to develop a live LaSota strain Newcastle Disease vaccine that can be freeze dried as […]

(9th October 2015) Efficient surveillance, early detection and rapid response to animal disease outbreaks are key steps for maintaining animal health, protecting human health and securing the income of poor […]

GALVmed recently participated in the 11th African Dairy Conference and Exhibition held at the Kenyatta International Conference Centre in Nairobi, Kenya from the September 23rd to 25th 2015. This year’s conference theme was […]

Nearly all deaths from rabies – the majority being children – are in Africa and Asia. A course of post-exposure treatment will save children. However, in the world’s poorest communities, […]

(31st August 2015) As we ended the financial year 2014/15, we take stock of our progress towards the delivery of livestock vaccines and other health products to poor people in Africa […]

GALVmed recently facilitated a two day training programme organised by Hester Biosciences for its team members. GALVmed is currently partnering with Hester in the setting up of a supply and […]

(26 August 2015) OIE, Africa Veterinary Technicians Association and GALVmed will host the first continental Africa veterinary para-professional conference from 13-15th October 2015 in Pretoria, South Africa. Para-professional veterinarians (PPV) are […]

(24 August 2015) In July, two GALVmed R&D colleagues visited a key collaboration site in Zambia. Angie Colston(Assistant Director, R&D) and Leonard Khaluhi (Veterinary Clinical Research Officer, R&D), who are both based in […]